Pharmacokinetic and Pharmacodynamic Considerations of Rifamycin Antibiotics for the Treatment of Tuberculosis
Expert Opinion on Drug Metabolism and Toxicology - United Kingdom
doi 10.1080/17425255.2019.1648432
Full Text
Open PDFAbstract
Available in full text
Date
July 30, 2019
Authors
Publisher
Informa UK Limited